Apriori gene set-based microarray analysis for disease classification using unlabeled data

Conference proceedings article


Authors/Editors


Strategic Research Themes

No matching items found.


Publication Details

Author listEngchuan W., Chan J.H.

PublisherElsevier

Publication year2013

Volume number23

Start page137

End page145

Number of pages9

ISSN1877-0509

URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84896959792&doi=10.1016%2fj.procs.2013.10.018&partnerID=40&md5=2f694aecce2effc11e169b344e2af117

LanguagesEnglish-Great Britain (EN-GB)


View in Web of Science | View on publisher site | View citing articles in Web of Science


Abstract

Gene set-based microarray analysis allows researchers to better analyze the gene expression data for studying complex diseases like cancer. By transforming gene expression data into another form using gene set information, the biomarkers will have higher discriminative power and should result in more accurate disease classification. This work compares two techniques for applying our previously developed NCFS-i-based method to deal with unlabeled data, i.e. to make predictive diagnosis. Seven cancer datasets that include 4 breast cancer and 3 lung cancer datasets were used in this study. The results show that inferring gene set activity using curated phenotype-correlated genes (PCOGs) sets of training data is a more robust method for applying NCFS-i-based method to work with unlabeled data, providing biologically relevant gene sets. ฉ 2013 The Authors.


Keywords

Cancer classificationFeature SelectionGene set activityMicroarray analysis


Last updated on 2023-02-10 at 07:35